Skip to main content
. 2015 Mar 6;48(1):63–70. doi: 10.4143/crt.2014.265

Table 2.

Comparisons of dosimetric characteristics and delivery efficiencies for different treatment techniques

Parameter 2F-3DCRT 3F-IMRT TH-IMRT TH-3DCRT p-value
2F-3DCRT vs. TH-3DCRT 3F-IMRT vs. TH-3DCRT TH-IMRT vs. TH-3DCRT
PTV
 CI 0.32 0.65 0.64 0.63 0.01a) 0.83 0.39
(0.3-0.35) (0.62-0.67) (0.60-0.68) (0.60-0.67)
 HI 1.06 1.09 1.05 1.05 0.39 0.01a) > 0.99
(1.05-1.07) (1.08-1.10) (1.05-1.06) (1.048-1.063)
Carotid artery
 V35 (%) 33.88 0.30 0.00 0.00 0.01a) 0.01a) > 0.99
(20.44-41.36) (0.05-0.30) (0.00-0.00) (0.00-0.00)
 V50 (%) 18.48 0.00 0.00 0.00 0.01a) > 0.99 > 0.99
(9.01-25.15) (0.00-0.00) (0.00-0.00) (0.00-0.00)
 V63 (%) 7.97 0.00 0.00 0.00 0.01a) > 0.99 > 0.99
(3.97-13.17) (0.00-0.00) (0.00-0.00) (0.00-0.00)
 Dmax (%) 69.82 38.71 29.23 30.31 0.01a) 0.01a) 0.09
(69.23-70.41) (35.55-43.52) (26.37-32.28) (27.53-34.15)
Spinal cord
 Dmax (%) 2.58 28.05 24.86 26.76 0.01a) 0.97 0.01a)
(2.38-3.55) (27.03-28.77) (23.48-27.52) (24.76-29.42)
 Planning time (min) 5.85 45.48 35.30 7.10 0.01a) 0.01a) 0.01a)
(5.50-6.25) (40.65-48.28) (32.91-40.78) (6.35-8.40)
 Delivery time (min) 2.06 2.48 2.90 2.86 0.01a) 0.01a) > 0.99
(1.99-2.11) (2.45-2.51) (2.81-2.97) (2.73-3.00)
 Pretreatment dosimetric QA × × - - -

Values are presented as median (interquartile range). 2F-3DCRT, 2-field 3-dimensional conformal radiotherapy; 3F-IMRT, 3-field intensity-modulated radiation therapy; TH-IMRT, TomoHelical IMRT; TH-3DCRT, TomoHelical 3DCRT; PTV, planning target volume; CI, conformity index; HI, homogeneity index; VD, the percentage of the organ volume that received D Gy or more; Dmax, maximum dose; QA, quality assurance.

a)

Statistically significant.